Imagination Is a Muscle: How Immersive Experiences Engage Visitors

Whether you’re an integrator, a designer or simply a label-defying creative, the EXPERIENCE is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

Host Bryan Meszaros welcomes Trent Oliver, Principal and Managing Director of Blue Telescope. For nearly two decades she’s led a team that designs, develops, and deploys award-winning technology-based exhibits.

This wide-ranging and insightful conversation covers everything from binge-watching during the pandemic to the challenges of communicating creative ideas to clients. Prototyping and creative collaboration are key to the process so that clients aren’t surprised by the final product.

“If you want to get people out after being at home for a year it better be cool.” -Trent Oliver

“Imagination is a muscle,” Oliver said. While it is challenging to invent and innovate, sometimes the greater challenge is communicating something unfamiliar to a client and helping them see how it can be used to engage visitors.

The technology used in exhibits ranges from virtual reality to location sensors, touch screens, and projection — but the technology isn’t the experience. Oliver points out that screens for the sake of technology aren’t enough. “We can be far more inventive and reactive and have surprise and joy and have your behavior be part of the total interaction,” Oliver said. The most immersive experiences can’t be replicated at home and depend on the viewer’s interaction. Centering the experience on visitors means the focus isn’t on the technology but how it is used to communicate “Every visitor wants to be seen and participate and be part of, not be blared at.” Oliver said. “Technology isn’t the experience.”

Oliver sees the interactive experience model expanding in the future as museums, theme parks, and retail converge to create new experiences for customers and visitors that give them something unique and surprising that they won’t find on screens at home. As Oliver said, “If you want to get people out after being at home for a year it better be cool.”

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions, helping craft the world’s most intriguing experiences.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More